ASC-ASCP Workgroup on the Emerging Roles in Cytopathology

Barbara A. Crothers, DO President, American Society of Cytopathology

Summer solstice has come and there is a sunny future for cytotechnology! Wonder why that is? You can find out by reading the upcoming Journal of the American Society of Cytopathology’s articles on the work from the ASC-ASCP Workgroup on the Emerging Roles in Cytopathology, to be published in the September edition. If you are a member of ASCP, watch for the joint publication in Laboratory Medicine.

There is an early release online on July 1st.

The titles of the articles are:

These manuscripts represent the culmination of over 4 years of collaborative work between the American Society for Clinical Pathology (ASCP) and our Society. The enduring projects that emerged from this effort are the highly successful Advanced Cytopathology Education (ACE) course and the ACE University—an online curriculum. 

ACE Live is intended to bring cutting-edge updates in cytopathology to the grass roots practitioners, those who may not have the resources to travel to the ASC annual meeting. The ACE course, usually co-sponsored with ASCP, was co-sponsored this year from May 4-6 with the American Society for Cytotechnology (ASCT) in Salt Lake City, UT. Based on the course evaluations, of 106 participants, 96% rated the course as highly satisfactory and enhancing knowledge and/or work skills. The focus for this year was on new cytology terminology—The Paris System for Reporting Urinary Cytopathology, The Bethesda System for Reporting Thyroid Cytopathology, and advances in pancreatic fine needle aspiration.

ACE University is a work-in-progress that is intended to provide practitioners and cytotechnology schools with educational modules to fill in practice gaps. The first module, on Rapid Onsite Evaluation (ROSE), has been developed and serves as the model for future topics. Completion of all available modules will earn the participant a certificate in advanced cytopathology practices and, hopefully, a chance to advance career progression and bring cytopathology into the future. Who knows? It may evolve into a required component for a Master’s degree in Cytotechnology for programs looking to supplement their curriculum.